Is CAH stock a Buy, Sell, or Hold?

Based on our analysis, CAH is currently a HOLD with moderate confidence. 📊 HOLD: CAH is fairly valued with market pricing in 0.9% annual growth. Fine to hold or accumulate slowly on dips.

What is the fair value of CAH stock?

Our analysis estimates the fair value range for CAH to be between $231.78 and $241.41. The current price is $234.57.

What is the analyst price target for CAH?

The average Wall Street analyst price target for CAH is $270.94. This implies a potential upside of 15.5% from current levels.

Cardinal Health (CAH) Stock: Buy, Sell, or Hold?

CAH - Cardinal Health, Inc.

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

$234.57

-1.45 (-0.61%) ▼

5d: -5.65%

30d: +0.18%

90d: +6.06%

HOLD

MODERATE Confidence

Protect Your CAH Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Oct 29, 2026

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Sep 4, 2026 at $247.18 · last confirmed Sep 9, 2026

Strength: 6.3/10

Get Alerted When CAH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: CAH is fairly valued with market pricing in 0.9% annual growth. Fine to hold or accumulate slowly on dips.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 17.8%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$380.34

Based on 10.9% avg growth

INTRINSIC VALUE TODAY

$236.16

0.7% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.9x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: CAH is currently trading at $234.57, which is considered slightly high relative to its 30-day fair value range of $231.78 to $241.41. The stock's valuation (Forward PE: 19.5) is in line with its historical norms (18.9). At these levels, the market is pricing in 0.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, CAH is in a strong uptrend. The price is currently testing key support at $232.60. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $270.94 (+15.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY HIGH

Historical Trading Range $231.78 - $241.41

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 63.8%

Protect Your Profits

Holding CAH? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Mixed technical signals (48/100)
BULLISH: High volume confirmation
BULLISH: Trading below Wall St target ($270.94)
NEUTRAL: Market pricing in 0.9% annual earnings growth - fairly valued
NEUTRAL: Bottoming setup forming (48/100) — watch for confirmation
CAUTION: 5-day price weakness (-5.6%) - monitor closely

Trading Range Analysis

30-Day Trading Range $231.78 - $241.41

Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $232.60

Resistance Level $249.29

Current Trend Strong Uptrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 19.46

Wall Street Target $270.94 (+15.5%)

Revenue Growth (YoY) 5.8%

Earnings Growth (YoY) 68.8%

Profit Margin 0.7%

Valuation Premium vs History +0.9% premium

PE vs Historical 19.5 vs 18.9 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +0.9% (market-implied from PE analysis)

1-Year Target $236.68 (+1%)

2-Year Target $238.81 (+2%)

3-Year Target $240.96 (+3%)

3-Yr Target (if PE normalizes) (PE: 19→19) PE COMPRESSION $234.04 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: 17.8%) $397.84 (+70%)

Base: (SPY PE: 19.5, Growth: 17.8%) $383.81 (+64%)

Bear: (PE: 16.5, Growth: 17.8%) $326.24 (+39%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (19x PE) as earnings recover.

Trailing PE: 33.24 | Current EPS (TTM): $7.10

Bull Case $440.80 (+88%)

Analyst growth 69.8%, PE expands to 36.6

Base Case $400.73 (+71%)

Market implied 69.8%, PE stable at 33.2

Bear Case $160.49 (-32%)

Severe decline -20.0%, PE contracts to 28.3

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 12, 2026 4:28 AM ET
Data refreshes hourly during market hours. Next update: 5:28 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is CAH showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for CAH.

Create Free Account

Already have an account? Log In

Top Rated Medical Distribution Stocks

Top-rated stocks in Medical Distribution by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
MCK McKesson Corporation	STRONG BUY 17 analysts	$987	51 HOLD
COR Cencora Inc.	STRONG BUY 14 analysts	$369	49 HOLD
HSIC Henry Schein Inc	HOLD 16 analysts	$98	46 HOLD
QIPT Quipt Home Medical Corp	STRONG BUY 5 analysts	$4	52 HOLD
OMI Owens & Minor Inc	HOLD 6 analysts	$6	46 HOLD

MCK McKesson Corporat…

51 HOLD

COR Cencora Inc.

49 HOLD

HSIC Henry Schein Inc

46 HOLD

QIPT Quipt Home Medica…

52 HOLD

OMI Owens & Minor Inc

46 HOLD

Advanced CAH Option Strategies

Professional options setups generated by AI based on today's CAH price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CAH

CAH Technical Chart CAH Price Prediction CAH Earnings Date CAH Investment Advisor CAH Fair Price Analyzer CAH Options Advisor CAH Options Chain CAH Options Analysis CAH Competitors

Compare CAH with Peers

CAH vs MCK
Which one to buy?

CAH vs BDX
Which one to buy?

CAH vs BAX
Which one to buy?

CAH vs BEN
Which one to buy?

CAH vs AFL
Which one to buy?

CAH vs COR
Winner: COR

HLF vs CAH

OMI vs CAH

EDAP vs CAH

Create New Comparison View All Competitors

Tradestie